{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:09Z","timestamp":1786120269148,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/aci.0b013e32834c3d30","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T19:20:45Z","timestamp":1317756045000},"page":"565-570","source":"Crossref","is-referenced-by-count":42,"title":["Anti-interleukin-5 antibody therapy in asthma and allerges"],"prefix":"10.1097","volume":"11","author":[{"given":"Jonathan","family":"Corren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210128","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V73.6.1504.1504","article-title":"Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF.","volume":"73","author":"Clutterbuck","year":"1989","journal-title":"Blood"},{"key":"R2-13-20210128","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood.V79.12.3101.bloodjournal79123101","article-title":"Interleukin-5, eosinophils, and disease.","volume":"79","author":"Sanderson","year":"1992","journal-title":"Blood"},{"key":"R3-13-20210128","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1172\/JCI115166","article-title":"Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.","volume":"87","author":"Hamid","year":"1991","journal-title":"J Clin Invest"},{"key":"R4-13-20210128","first-page":"358","article-title":"Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.","volume":"21","author":"Schrezenmeier","year":"1993","journal-title":"Exp Hematol"},{"key":"R5-13-20210128","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/S0923-1811(03)00149-X","article-title":"Heterogeneity of interleukin 5 genetic background in atopic dermatitis patients: significant difference between those with blood eosinophilia and normal eosinophil levels.","volume":"33","author":"Yamamoto","year":"2003","journal-title":"J Derm Sci"},{"key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.168.5.2464","article-title":"IL-5 promotes eosinophil trafficking to the esophagus.","volume":"168","author":"Ishra","year":"2002","journal-title":"J Immunol"},{"key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma.","volume":"323","author":"Bousquet","year":"1990","journal-title":"N Engl J Med"},{"key":"R8-13-20210128","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/ajrccm.156.3.9610033","article-title":"Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma.","volume":"156","author":"Humbert","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-13-20210128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0091-6749(93)90175-F","article-title":"Activation of CD4 T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma.","volume":"92","author":"Robinson","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"R11-13-20210128","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1183\/09031936.03.00027302","article-title":"Monoclonal antiinterleukin-5 treatment suppresses eosinophil but not T-cell functions.","volume":"21","author":"Buttner","year":"2003","journal-title":"Eur Respir J"},{"key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","article-title":"A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.","volume":"176","author":"Flood-Page","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.","volume":"360","author":"Nair","year":"2009","journal-title":"N Engl J Med"},{"key":"R14-13-20210128","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma.","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2006.02.042","article-title":"Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report.","volume":"117","author":"Klion","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1055\/s-2006-939519","article-title":"Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants.","volume":"27","author":"Roufosse","year":"2006","journal-title":"Semin Respir Crit Care Med"},{"key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199910073411503","article-title":"Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia.","volume":"341","author":"Simon","year":"1999","journal-title":"N Engl J Med"},{"key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.iac.2007.07.006","article-title":"Approach to the therapy of hypereosinophilic syndromes.","volume":"27","author":"Klion","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.leukres.2005.11.011","article-title":"FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature.","volume":"30","author":"Pardanani","year":"2006","journal-title":"Leuk Res"},{"key":"R20-13-20210128","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0002-9343(03)00475-3","article-title":"Reversal of hypereosinophilic syndrome and lymphomatoid papulosis with mepolizumab and imatinib.","volume":"115","author":"Koury","year":"2003","journal-title":"Am J Med"},{"key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jaci.2003.10.049","article-title":"Antiinterleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.","volume":"113","author":"Garrett","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R22-13-20210128","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa070812","article-title":"Treatment of the hypereosinophilic syndrome with mepolizumab.","volume":"358","author":"Rothenberg","year":"2008","journal-title":"N Engl J Med"},{"key":"R23-13-20210128","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1053\/j.gastro.2007.08.017","article-title":"Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment.","volume":"133","author":"Furuta","year":"2007","journal-title":"Gastroenterology"},{"key":"R24-13-20210128","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","article-title":"Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.","volume":"118","author":"Stein","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"R25-13-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/gut.2009.178558","article-title":"Antiinterleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial.","volume":"59","author":"Straumann","year":"2010","journal-title":"Gut"},{"key":"R27-13-20210128","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","article-title":"Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis.","volume":"60","author":"Oldhoff","year":"2005","journal-title":"Allergy"},{"key":"R28-13-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000095299","article-title":"No effect of antiinterleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients.","volume":"141","author":"Oldhoff","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"R29-13-20210128","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","article-title":"Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome.","volume":"125","author":"Kim","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R30-13-20210128","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","article-title":"Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps.","volume":"118","author":"Gevaert","year":"2006","journal-title":"J Allergy Clin Immunol"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ACI.0b013e32834c3d30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:20:16Z","timestamp":1786047616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130832-201112000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e32834c3d30","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717970993.793469386","asserted-by":"object"}]},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}